Chen CP - Search Results

1

A phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with radiotherapy and chemotherapy in patients with rectal cancer.

Huang CW, Hu HM, Hsu WH, Chen CY, Huang MY, Chen CP, Wei PL, Shen BN, Wang JY. Huang CW, et al. Among authors: chen cy, chen cp. Nanomedicine (Lond). 2023 Mar;18(6):511-524. doi: 10.2217/nnm-2022-0186. Epub 2023 May 11. Nanomedicine (Lond). 2023. PMID: 37166053 Free article.

2

Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer.

Lin CC, Chen TH, Wu YC, Fang CY, Wang JY, Chen CP, Huang KW, Jiang JK. Lin CC, et al. Among authors: chen th, chen cp. Ann Surg Oncol. 2021 Mar;28(3):1762-1776. doi: 10.1245/s10434-020-08914-8. Epub 2020 Sep 1. Ann Surg Oncol. 2021. PMID: 32875464

3

Ramucirumab in the second-line treatment of metastatic colorectal cancer: a narrative review of literature from clinical trials.

Chen CP, Ke TW, Cheng R, Wang JY. Chen CP, et al. Transl Cancer Res. 2020 Sep;9(9):5645-5654. doi: 10.21037/tcr-20-608. Transl Cancer Res. 2020. PMID: 35117928 Free PMC article. Review.

4

Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study.

Lin CY, Lin TH, Chen CC, Chen MC, Chen CP. Lin CY, et al. Among authors: chen cc, chen mc, chen cp. PLoS One. 2018 Jan 5;13(1):e0190497. doi: 10.1371/journal.pone.0190497. eCollection 2018. PLoS One. 2018. PMID: 29304109 Free PMC article.

5

A postmarketing surveillance study on erbitux (cetuximab) in patients with metastatic colorectal cancer refractory to irinotecan-containing treatment.

Huang WT, Chen HH, Yeh CH, Lu YC, Hwang WS, Huang JS, Chen CP, Lin PC, Uen WC, Lee YC, Wang HM, Wu HC, Chen JS, Kao RH, Huang CC, Jeng HH, Lin CJ, Hsieh RK. Huang WT, et al. Among authors: chen hh, chen js, chen cp. J Investig Med. 2013 Oct;61(7):1108-14. doi: 10.2310/JIM.0b013e3182a6799d. J Investig Med. 2013. PMID: 24013526

6

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.

Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.

7

The Significant Contribution of Interleukin-16 Genotypes, Smoking, Alcohol Drinking, and Helicobacter Pylori Infection to Gastric Cancer.

Fu CK, Mong MC, Tzeng HE, Yang MD, Chen JC, Hsia TC, Hsia NY, Tsai CW, Chang WS, Chen CP, Bau DT. Fu CK, et al. Among authors: chen jc, chen cp. In Vivo. 2024 Jan-Feb;38(1):90-97. doi: 10.21873/invivo.13414. In Vivo. 2024. PMID: 38148080 Free PMC article.

8

Tattooing or Metallic Clip Placement? A Review of the Outcome Surrounding Preoperative Localization Methods in Minimally Invasive Anterior Resection Performed at a Single Center.

Lin CL, Chen CP, Chiang FF, Chen CC, Chen MC, Chen CT, Lin CY, Cheng HH, Shao YC. Lin CL, et al. Among authors: chen cc, chen ct, chen mc, chen cp. Surg Laparosc Endosc Percutan Tech. 2021 Oct 14;32(1):101-106. doi: 10.1097/SLE.0000000000001010. Surg Laparosc Endosc Percutan Tech. 2021. PMID: 34653111 Free PMC article. Review.

9

Association of Adiponectin Genotypes With Colorectal Cancer Susceptibility in Taiwan.

Hung YC, Chang WS, Chou AK, Pei JS, Yang MD, Yang HR, Yang TM, Wang YC, Hsiau YC, Chen CP, Chen CC, Yu CC, Tsai CW, Bau DT. Hung YC, et al. Among authors: chen cc, chen cp. Anticancer Res. 2020 Mar;40(3):1297-1306. doi: 10.21873/anticanres.14071. Anticancer Res. 2020. PMID: 32132026

10

Contribution of 5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase Genotypes to Colorectal Cancer in Taiwan.

Wu MH, Chen CH, Chen CP, Huang TL, Yueh TC, Wang ZH, Tsai CW, Pei JS, Mong MC, Yang YC, Bau DT, Chang WS. Wu MH, et al. Among authors: chen ch, chen cp. Anticancer Res. 2022 May;42(5):2375-2382. doi: 10.21873/anticanres.15716. Anticancer Res. 2022. PMID: 35489763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,935 results

Search Page